Učitavanje...
Serum sRANKL and sRANKL/OPG ratio: Novel biomarkers in non-small cell lung cancer
Osteoprotegerin (OPG) and soluble receptor activator of nuclear factor-κB ligand (sRANKL) are bone-regulating molecules. The two molecules have each been indicated to be involved in carcinogenesis. However, the diagnostic significance in non-small cell lung cancer (NSCLC) remains to be investigated....
Spremljeno u:
| Izdano u: | Oncol Lett |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774468/ https://ncbi.nlm.nih.gov/pubmed/26998159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4166 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|